Why the study?
Prosthetic valve thrombosis remains a significant, life-threatening issue despite patient education, warranting evaluation of its incidence, characteristics, and outcomes with streptokinase thrombolysis.
Does thrombolysis with streptokinase effectively treat mechanical prosthetic valve thrombosis in patients with mechanical valve replacements?
Population
500 valve replacement patients (aged 25-71), including 32 diagnosed with PVT
Comparison
Streptokinase thrombolysis for PVT
Design
Retrospective study
Key result
Thrombolysis with streptokinase for mechanical prosthetic valve thrombosis was highly effective, achieving an 84.37% success rate and 90.62% in-hospital survival.
Authors
Loading...
May support streptokinase for mechanical prosthetic valve thrombosis; leaves open need for randomized trials before practice change.
Cohort (n=500)
No
Does thrombolysis with streptokinase effectively treat mechanical prosthetic valve thrombosis in patients with mechanical valve replacements?
Streptokinase thrombolysis is a highly effective treatment for mechanical prosthetic valve thrombosis, achieving an 84.37% success rate with manageable complications.
Iragavarapu et al. (2025) conducted a cohort in Prosthetic valve thrombosis (n=500). Streptokinase was evaluated on Thrombolytic therapy success rate. Thrombolysis with streptokinase for mechanical prosthetic valve thrombosis was highly effective, achieving an 84.37% success rate and 90.62% in-hospital survival.